Alerts will be sent to your verified email
Verify EmailAJOONI
5
10
20
Balance sheet of Ajooni Biotech is strong.
It shouldn't have solvency or liquidity issues.
Yes, The net debt of Ajooni Biotech is increasing.
Latest net debt of Ajooni Biotech is ₹10.14 Crs as of Dec-25.
This is greater than Mar-25 when it was -₹11.55 Crs.
Yes, profit is increasing.
The profit of Ajooni Biotech is ₹4.91 Crs for TTM, ₹3.37 Crs for Mar 2025 and ₹2.16 Crs for Mar 2024.
The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Ajooni Biotech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
Companies resources are majorly tied in miscellaneous assets